Hyaluronic Acid Profhilo® Reduces Skin Inflammation & Neuroimmune Changes in Atopic Dermatitis | Breakthrough Mouse Study
Pathophysiology of Atopic Dermatitis and Neuroimmune Crosstalk
Atopic dermatitis involves complex immune activation pathways, including elevated Th2 cytokines, mast cell activation, and disrupted skin barrier proteins. Increasing evidence indicates that spinal neuroimmune signaling contributes to chronic itch and inflammatory amplification. Understanding how peripheral skin inflammation influences central nervous system pathways is crucial for developing targeted therapies that address both local and systemic components of the disease.
Mechanisms of Hyaluronic Acid in Inflammatory Modulation
Hyaluronic acid is a key extracellular matrix component with hydrating, regenerative, and immunomodulatory properties. In inflammatory environments, it influences cytokine signaling, cellular migration, and tissue remodeling. Profhilo®, a stabilized hyaluronic acid complex, may exert anti-inflammatory effects by downregulating pro-inflammatory mediators while enhancing tissue repair pathways, thereby improving both dermal architecture and immune balance.
Experimental Design in the Mouse Model of Atopic Dermatitis
The study employed a controlled mouse model to simulate atopic dermatitis-like inflammation. Clinical scoring, histological examination, and molecular analyses were used to assess epidermal thickness, immune cell infiltration, and cytokine expression. Additionally, spinal cord tissues were evaluated to examine neuroimmune alterations, providing a comprehensive understanding of both peripheral and central inflammatory modulation following Profiled® administration.
Hyaluronic acid research, Profhilo study, atopic dermatitis mouse model, skin inflammation treatment, neuroimmune modulation, dermatology research, inflammatory skin disease study, cytokine regulation research, bio-remodeling therapy, translational dermatology research,

Comments
Post a Comment